News By Tag
News By Place
Philip Johnson & Ret.Chief Judge Michel to Present at Life Sciences IP Due Diligence
Mr. Johnson and Judge Michel will engage in a fireside chat on Global Factors Influencing IP Due Diligence. Reacting to this unique and important topic, Mr. Johnson and Judge Michel commented,
"Advance assessment of freedom to operate and the need to secure patents and possibly licenses in both foreign markets and the United States is so critical to all parties active in health science industries that IP Diligence must be everyone's top priority. That means staying current on new developments in law as well as science, including impending changes in the PTO, the courts and the Congress. And, deepening understandings so as to enable realistic and reliable predictions on patentability, scope of protection, potential liabilities, valuations, damages and injunctions."
In response, Lisa J. Piccolo, Senior Director of Programming at ACI noted, "we are honored to have Mr. Johnson and Judge Michel participate in this year's conference. Their presence at the event is testament to the "must-attend"
Julie Kurzrok, Legal Analyst and Conference Director at ACI, remarked, "We are proud to host the premier event for life sciences practitioners to gather and strategize the design and process for a successful and cost-effective IP due diligence analysis. Kurzrok added, "We look forward to bringing this year's event to the world's largest life sciences hub, Boston, and are honored to work with this stellar group of life sciences professionals."
In addition to Mr. Johnson and Judge Michel, the conference faculty features industry leaders from over 20 pharmaceutical and biotech companies, , and leading attorneys from more than a dozen top law firms.
Full information on the forum can be found at www.americanconference.com/